| Ross L, Hansen D, Maltez N, Morrisroe K, Kumar K, Walker J, Stevens W, Sahhar J, Ngian GS, Host L, Nikpour M, Proudman S. The effect of calcium channel blockers on digital ulcers in systemic sclerosis: data from a prospective cohort study. Clin Rheumatol. 2024 Jan;43(1):269-276. doi: 10.1007/s10067-023-06796-1. Epub 2023 Nov 3. |
| Deakin CT, Littlejohn GO, Griffiths H, Ciciriello S, O'Sullivan C, Smith T, Youssef P, Bird P; OPAL consortium. Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost-savings. Intern Med J. 2024 May;54(5):795-801. doi: 10.1111/imj.16296. Epub 2023 Nov 27. |
| Nielsen W, Strand V, Simon LS, Parodis I, Kim AHJ, Desai M, Enman Y, Wallace D, Chaichian Y, Navarra S, Aranow C, MacKay M, Trotter K, Tayer-Shifman OE, Duarte-Garcia A, Shan Tam L, Ugarte-Gil MF, PonsEstel GJ, Reynolds JA, Nikpour M, Hoi A, Romero-Diaz J, Papachristos D, Aggarwal A, Mok CC, Fujio K, Ramsey-Goldman R, Howe A, Kia BN, Bonilla D, Thumboo J, Mosca M, Aringer M, Johnson SR, Drucker AM, Morand E, Bruce I, Touma Z; OMERACT SLE Working Group. OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome Set. Semin Arthritis Rheum. 2024 Apr;65:152380. doi: 10.1016/j.semarthrit.2024.152380. Epub 2024 Jan 14. |
| Nindra U, Shivasabesan G, Mellor R, Chua W, Ng W, Karikios D, Richards B, Liu J. Evaluating Systemic Burnout in Medical Oncology Through a National Oncology Mentorship Program. JCO Oncol Pract. 2024 Apr;20(4):549-557. doi: 10.1200/OP.23.00469. Epub 2024 Jan 30. |
| Fairley JL, Hansen D, Day J, Proudman S, Sahhar J, Ngian GS, Walker J, Host LV, Morrisroe K, Stevens W, Ross L, Nikpour M. Proximal weakness and creatine kinase elevation in systemic sclerosis: Clinical correlates, prognosis and functional implications. Semin Arthritis Rheum. 2024 Apr;65:152363. doi: 10.1016/j.semarthrit.2024.152363. Epub 2024 Jan 24. |
| Parker MJS, Jee AS, Hansen D, Proudman S, Youssef P, Kenna TJ, Stevens W, Nikpour M, Sahhar J, Corte TJ. Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis. Rheumatology (Oxford). 2024 Nov 1;63(11):2981-2988. doi: 10.1093/rheumatology/keae110. |
| Katsumata Y, Inoue E, Harigai M, Cho J, Louthrenoo W, Hoi A, Golder V, Lau CS, Lateef A, Chen YH, Luo SF, Wu YJ, Hamijoyo L, Li Z, Sockalingam S, Navarra S, Zamora L, Hao Y, Zhang Z, Chan M, Oon S, Ng K, Kikuchi J, Takeuchi T, Goldblatt F, O'Neill S, Tugnet N, Law AHN, Bae SC, Tanaka Y, Ohkubo N, Kumar S, Kandane-Rathnayake R, Nikpour M, Morand EF; Asia-Pacific Lupus Collaboration. Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study. Ann Rheum Dis. 2024 Jul 15;83(8):998-1005. doi: 10.1136/ard-2023-225369. |
| Campbell TM, Finzel S, Siddle H, Christensen R, Nielsen SM, Najm A, Otobo TM, Sahbudin I, Sinnathurai P, Stok KS, Touma Z, April KT, Grosskleg S, Tugwell P, Richards B. Navigating the path of progress: The OMERACT 2023 emerging leaders program. Semin Arthritis Rheum. 2024 Jun;66:152414. doi: 10.1016/j.semarthrit.2024.152414. Epub 2024 Feb 21. |
| Littlejohn G, Leadbetter J, Butcher BE, Feletar M, O'Sullivan C, Smith T, Witcombe D, Ng HY, Youssef P. Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia. Clin Rheumatol. 2024 May;43(5):1579-1589. doi: 10.1007/s10067-024-06930-7. Epub 2024 Mar 9. |
| Ross L, McDonald J, Hansen D, Fairley J, Wicks C, Proudman S, Walker J, Sahhar J, Ngian GS, Host L, Stevens W, Philip J, Nikpour M. Quantifying the Need for Specialist Palliative Care Management in Patients With Systemic Sclerosis. Arthritis Care Res (Hoboken). 2024 Jul;76(7):964-972. doi: 10.1002/acr.25325. Epub 2024 May 15. |
| Gregory K, Hansen D, Penglase R, Apostolopoulos D, Ngian GS, Stevens W, Morrisroe K, Ferdowsi N, Ross L, Walker J, Cooley H, Youssef P, Tymms K, Host L, Proudman S, Moore J, Nikpour M, Sahhar J. Outcomes of Patients With Diffuse Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation Treated With Conventional Therapy. Arthritis Rheumatol. 2024 Aug;76(8):1294-1302. doi: 10.1002/art.42850. Epub 2024 May 8. |
| Fairley JL, Hansen D, Proudman S, Sahhar J, Ngian GS, Walker J, Host LV, La Gerche A, Prior D, Burns A, Morrisroe K, Stevens W, Nikpour M, Ross L. Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis. Semin Arthritis Rheum. 2024 Jun;66:152443. doi: 10.1016/j.semarthrit.2024.152443. Epub 2024 Apr 6. |
| McColl H, Cordina R, Lal S, Parker M, Hunyor I, Medi C, Gray B. Recurrent immunosuppressive-responsive myocarditis in a patient with desmoplakin cardiomyopathy: a case report. Eur Heart J Case Rep. 2024 Mar 13;8(3):ytae129. doi: 10.1093/ehjcr/ytae129. |
| Huang V, Ciciriello S, Nikpour M, Oon S, Day J. Diagnosing and characterizing inflammatory myopathies at an Australian tertiary public hospital: Resource utilization and direct healthcare costs. Int J Rheum Dis. 2024 Apr;27(4):e15153. doi: 10.1111/1756-185X.15153. |
| de Luca Montes RA, Huq M, Godfrey T, Oon S, Calderone A, Kandane-Rathnayake R, Louthrenoo W, Luo SF, Jan Wu YJ, Golder V, Lateef A, Navarra SV, Zamora L, Hamijoyo L, Sockalingam S, An Y, Li Z, Katsumata Y, Harigai M, Chan M, Goldblatt F, O'Neill S, Lau CS, Cho J, Hoi A, Karyekar CS, Morand EF, Nikpour M. Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study. Adv Rheumatol. 2024 May 8;64(1):38. doi: 10.1186/s42358-024-00366-y. |
| Ciciriello S, Littlejohn GO, Treuer T, Gibson KA, Haladyj E, Youssef P, Bird P, O'Sullivan C, Smith T, Deakin CT. Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL dataset. Clin Exp Rheumatol. 2024 Sep;42(9):1763-1772. doi: 10.55563/clinexprheumatol/n0kjax. Epub 2024 May 1. |
| Hao Y, Oon S, Nikpour M. Efficacy and safety of treat-to-target strategy studies in rheumatic diseases: A systematic review and meta-analysis. Semin Arthritis Rheum. 2024 Aug;67:152465. doi: 10.1016/j.semarthrit.2024.152465. Epub 2024 May 21. |
| Pisaniello HL, Lester SE, Russell O, Black R, Tieu J, Richards B, Barrett C, Lassere M, March L, Buchbinder R, Hill C, Whittle SL. The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD). Ann Rheum Dis. 2024 Sep 30;83(10):1400-1402. doi: 10.1136/ard-2024-225696. |
| Golder V, Kandane-Rathnayake R, Li N, Louthrenoo W, Chen YH, Cho J, Lateef A, Hamijoyo L, Luo SF, Wu YJ, Navarra SV, Zamora L, Li Z, Sockalingam S, Katsumata Y, Harigai M, Hao Y, Zhang Z, Basnayake D, Chan M, Kikuchi J, Takeuchi T, Bae SC, Goldblatt F, Oon S, O'Neill S, Ng K, Law A, Tugnet N, Kumar S, Tee C, Tee M, Ohkubo N, Tanaka Y, Lau CS, Hoi A, Nikpour M, Morand EF; Asia Pacific Lupus Collaboration. Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study. Lancet Rheumatol. 2024 Aug;6(8):e528-e536. doi: 10.1016/S2665-9913(24)00121-8. Epub 2024 Jun 11. |
| Quinlivan A, Neuen D, Hansen D, Stevens W, Ross L, Ferdowsi N, Proudman SM, Walker JG, Sahhar J, Ngian GS, Apostolopoulos D, Host LV, Major G, Basnayake C, Morrisroe K, Nikpour M. The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomes. Arthritis Res Ther. 2024 Jun 25;26(1):124. doi: 10.1186/s13075-024-03355-0. |
| Ross L, Hansen D, Proudman S, Khanna D, Herrick AL, Stevens W, Baron M, Nikpour M; Australian Scleroderma Interest Group (ASIG), Canadian Scleroderma Research Group (CSRG), the Scleroderma Clinical Trials Consortium Activity Index Working Group. Development and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity Index. Arthritis Rheumatol. 2024 Nov;76(11):1635-1644. doi: 10.1002/art.42939. Epub 2024 Aug 26. |
| Fairley JL, O'Rourke R, Puranik R, Nikpour M. Cardiac magnetic resonance imaging in systemic sclerosis: Heart involvement in high-resolution. Rheumatol Immunol Res. 2024 Jul 15;5(2):83-92. doi: 10.1515/rir-2024-0011. |
| Nielsen W, Strand V, Simon L, Pinsker E, Bonilla D, Morand E, Thumboo J, Aringer M, Mosca M, Bruce I, Parodis I, Kim A, Desai M, Enman Y, Shea B, Wallace DJ, Chaichian Y, Navarra S, Aranow C, Mackay M, Trotter K, Tayer-Shifman OE, Duarte-García A, Shan Tam L, Ugarte-Gil MF, Pons-Estel GJ, Reynolds JA, Nikpour M, Hoi A, Romero-Diaz J, Aggarwal A, Mok CC, Fujio K, Ramsey-Goldman R, Gladman DD, Arnaud L, Bultink IEM, Ruiz-Irastorza G, Inês LS, Appenzeller S, Dobrowolski C, Clarke AE, Kamen DL, Barraclough M, Tani C, Gómez-Puerta JA, Werth VP, Katz P, Nowrouzi-Kia B, Johnson SR, Drucker AM, Touma Z; OMERACT SLE Working Group. OMERACT systemic lupus erythematosus domain survey. Semin Arthritis Rheum. 2024 Oct;68:152520. doi: 10.1016/j.semarthrit.2024.152520. Epub 2024 Jul 24. |
| Fairley JL, Ross L, Nikpour M. Heart involvement in systemic sclerosis: emerging concepts. Curr Opin Rheumatol. 2024 Nov 1;36(6):393-400. doi: 10.1097/BOR.0000000000001038. Epub 2024 Aug 9. |
| Brown Z, Morrisroe K, Hansen D, Stevens W, Proudman S, Teng GG, Low A, Nikpour M. Predictive accuracy of the ASIG algorithm in a prospective systemic sclerosis cohort undergoing annual screening for pulmonary arterial hypertension. Intern Med J. 2024 Sep;54(9):1561-1566. doi: 10.1111/imj.16468. Epub 2024 Aug 13. |
| Fairley JL, Hansen D, Baron M, Proudman S, Sahhar J, Ngian GS, Walker J, Host LV, Morrisroe K, Stevens W, Nikpour M, Ross L. Investigating the trajectory of functional disability in systemic sclerosis: group-based trajectory modelling of the Health Assessment Questionnaire-Disability Index. Clin Exp Rheumatol. 2024 Aug;42(8):1581-1589. doi: 10.55563/clinexprheumatol/9erk5j. Epub 2024 Aug 2. |
| Fairley JL, Hansen D, Proudman S, Baron M, Sahhar J, Ngian GS, Walker J, Host LV, Morrisroe K, Stevens W, Ross L, Nikpour M. The burden and determinants of fatigue in incident and prevalent systemic sclerosis. Clin Exp Rheumatol. 2024 Aug;42(8):1669-1674. doi: 10.55563/clinexprheumatol/6528od. Epub 2024 Aug 14. |
| Parodis I, Lindblom J, Levy RA, Zen M, Cetrez N, Gomez A, Oon S, Henning C, Khamashta M, Quasny HA, Chauhan D, Askanase A, van Vollenhoven R, Nikpour M. Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials. Lancet Rheumatol. 2024 Nov;6(11):e751-e761. doi: 10.1016/S2665-9913(24)00162-0. Epub 2024 Aug 26. |
| Virgili-Gervais G, Matthews B, Nassar EL, Carrier ME, Kwakkenbos L, Pauling JD, Bartlett SJ, Gietzen A, Gottesman K, Guillot G, Hudson M, Hummers LK, Lawrie-Jones A, Malcarne VL, Mayes MD, Richard M, Sauvé M, Wojeck RK, Mouthon L, Benedetti A, Thombs BD; Scleroderma Patient-centered Intervention Network investigators. The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study. Lancet Rheumatol. 2024 Oct;6(10):e684-e692. doi: 10.1016/S2665-9913(24)00189-9. Epub 2024 Aug 28. |
| Quinlivan A, Hansen D, Stevens W, Ross L, Ferdowsi N, Proudman SM, Walker JG, Sahhar J, Ngian GS, Apostolopoulos D, Host LV, Major G, Basnayake C, Morrisroe K, Nikpour M. Prevalence and Outcomes of Gastrointestinal Manifestations in an Australian Scleroderma Cohort. Arthritis Care Res (Hoboken). 2024 Dec;76(12):1686-1695. doi: 10.1002/acr.25426. Epub 2024 Oct 4. |
| Melman A, Teng MJ, Coombs DM, Li Q, Billot L, Lung T, Rogan E, Marabani M, Hutchings O, Zadro JR, Maher CG, Machado GC; Back@Home Investigators. Process and implementation evaluation of a virtual hospital model of care for low back pain (Back@Home). Emerg Med Australas. 2024 Dec;36(6):929-937. doi: 10.1111/1742-6723.14487. Epub 2024 Sep 13. |
| Hao Y, Hansen D, Louthrenoo W, Chen YH, Cho J, Lateef A, Hamijoyo L, Luo SF, Wu YJ, Navarra S, Zamora L, Li Z, Sockalingam S, Katsumata Y, Harigai M, Zhang Z, Chan M, Kikuchi J, Takeuchi T, Bae SC, Goldblatt F, O'Neill S, Ng K, Basnayake BMDB, Tugnet N, Tanaka Y, Lau CS, Li N, Golder V, Hoi A, Kandane-Rathnayake R, Morand E, Oon S, Nikpour M. Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosus. Lupus Sci Med. 2024 Sep 18;11(2):e001217. doi: 10.1136/lupus-2024-001217. |
| Cho C, Bak G, Sumpton D, Richards B, Sherrington C. Perspectives of healthcare providers on osteoporosis, falls and fracture risk: a systematic review and thematic synthesis of qualitative studies. Arch Osteoporos. 2024 Sep 24;19(1):90. doi: 10.1007/s11657-024-01446-8. |
| Comachio J, Purcell K, Brady B, Thiveos T, Strkljevic I, Shu C, Carvalho-E-Silva AP, Nikpour M, Anderson DB; SydneyMSK Diversity, Inclusion, Culture, and Equity portfolio (DICE). Improving Musculoskeletal Health by Incorporating Equity, Diversity, and Inclusion Approaches Into Research Practices. Musculoskeletal Care. 2024 Dec;22(4):e1943. doi: 10.1002/msc.1943. |
| McLennan C, Sherrington C, Tilden W, Jennings M, Richards B, Hill AM, Fairbrother G, Ling F, Naganathan V, Haynes A. Considerations across multiple stakeholder groups when implementing fall prevention programs in the acute hospital setting: a qualitative study. Age Ageing. 2024 Oct 1;53(10):afae208. doi: 10.1093/ageing/afae208. |
| Williamson L, Hao Y, Basnayake C, Oon S, Nikpour M. Systematic review of treatments for the gastrointestinal manifestations of systemic lupus erythematosus. Semin Arthritis Rheum. 2024 Dec;69:152567. doi: 10.1016/j.semarthrit.2024.152567. Epub 2024 Oct 28. |
| Shah RC, Morrisroe K, Stevens W, Ferdowsi N, Proudman S, Nikpour M, Ross LJ. Scleroderma renal crisis, an increasingly rare but persistently challenging condition: a retrospective cohort study. Rheumatol Adv Pract. 2024 Oct 28;8(4):rkae131. doi: 10.1093/rap/rkae131. |
| Fairley JL, Hansen D, Proudman S, Sahhar J, Ngian GS, Apostolopoulos D, Walker J, Host LV, Stevens W, Ferdowsi N, Tabesh M, Nikpour M, Ross L. The frequency and clinical associations of opioid use in systemic sclerosis. Rheumatol Adv Pract. 2024 Nov 15;8(4):rkae144. doi: 10.1093/rap/rkae144. |
| McLachlan H, Maher CG, Lin CC, Billot L, Day RO, Ivers R, Underwood M, McLachlan AJ, Richards B, Finnerup NB, Ferreira GE; DREAM Study Group. DREAM: an adaptive, randomised, placebo-controlled trial of duloxetine for reducing leg pain in people with chronic sciatica-trial protocol. BMJ Open. 2024 Dec 31;14(12):e096796. doi: 10.1136/bmjopen-2024-096796. |
| Baldwin JN, Purcell K, Hassett L, Tiedemann A, Pinheiro M, Savage R, Wang B, Haynes A, West K, Noetel M, Richards B, Jennings M, Gupta S, Smith BJ, Treacy D, Halliday M, Harvey LA, Phongsavan P, Rogers K, Howard K, Bauman A, Hamdorf P, Shaw A, Walkley J, Dwyer G, Lonsdale C, Reece L, Clutterbuck G, Lovitt L, Sturnieks D, Sherrington C. Promotion of Physical Activity by Health Professionals (PROMOTE-PA): protocol for effectiveness outcomes in a hybrid type I effectiveness-implementation cluster randomised controlled trial. BMJ Nutr Prev Health. 2024 Aug 6;7(2):e000901. doi: 10.1136/bmjnph-2024-000901. |
| Parker MJS, Lilleker JB, Chinoy H. Adult idiopathic inflammatory myopathies. Medicine (Baltimore). 2024. doi:10.1016/j.mpmed.2024.09.005 |